Hospital
Sentara Albemarle Regional Medical Center
Sentara Albemarle Regional Medical Center was paid $13.82M by Medicaid between Jan 2018 and Dec 2024, across 103 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoSENTARA ALBEMARLE REGIONAL MEDICAL CENTER
ELIZABETH CITY, NC 27909
ELIZABETH CITY, NC 27909
33aNPI1245211168assigned 11/08/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.82M
24GClaims333,506
24DCodes billed103
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#40 of 92
Median peer was paid$11.47M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HANCOCK, MELINDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,256 | $1.19M | |
| 2019 | 39,960 | $1.39M | |
| 2020 | 30,301 | $795K | |
| 2021 | 55,280 | $1.97M | |
| 2022 | 55,838 | $2.65M | |
| 2023 | 58,054 | $2.58M | |
| 2024incomplete | 64,817 | $3.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 44,619 | 38,637 | $4.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 22,923 | 19,401 | $3.47M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 8,232 | 6,894 | $1.47M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.6% | 12,322 | 10,567 | $638K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.4% | 10,636 | 3,149 | $605K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.6% | 13,177 | 10,989 | $364K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 12,254 | 10,144 | $359K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 7,632 | 6,096 | $286K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 6,457 | 5,611 | $270K |
| 0240U | 1.2% | 1,105 | 943 | $161K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.2% | 2,648 | 726 | $160K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 23,449 | 19,324 | $145K |
91 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,744 | $135K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15,631 | $103K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,215 | $102K |
| J3490 | Unclassified drugs | <1% | 76,570 | $91K |
| 80053 | Comprehensive metabolic panel | <1% | 11,108 | $75K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,056 | $70K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,231 | $61K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 255 | $60K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 803 | $51K |
| 81001 | <1% | 16,033 | $49K | |
| 0225U | <1% | 136 | $48K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 812 | $45K |
| 84484 | <1% | 6,899 | $45K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 106 | $40K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,212 | $31K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,204 | $30K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,193 | $30K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,286 | $25K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 606 | $23K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,496 | $23K |
| 85027 | <1% | 4,439 | $23K | |
| G0378 | Hospital observation service, per hour | <1% | 196 | $17K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 80 | $16K |
| 59050 | <1% | 105 | $15K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 25 | $14K |
| 83690 | <1% | 1,833 | $11K | |
| 81025 | <1% | 1,333 | $11K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 171 | $11K |
| 84703 | <1% | 1,315 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 131 | $9K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 54 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 192 | $9K |
| 80061 | Lipid panel | <1% | 655 | $7K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 50 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 179 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 360 | $5K |
| 86703 | <1% | 434 | $5K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 14 | $5K |
| 87081 | <1% | 560 | $4K | |
| 80076 | <1% | 553 | $4K | |
| 96376 | <1% | 73 | $4K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 37 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 80 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 234 | $3K |
| 84439 | <1% | 338 | $3K | |
| 83880 | <1% | 116 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $2K |
| 83735 | <1% | 445 | $2K | |
| 81003 | <1% | 801 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 204 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 256 | $1K |
| 86803 | <1% | 95 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 588 | $1K |
| 83605 | <1% | 103 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,648 | $1K |
| 87077 | <1% | 124 | $1K | |
| 82962 | <1% | 417 | $955.29 | |
| 80047 | <1% | 142 | $927.55 | |
| 85379 | <1% | 102 | $909.64 | |
| 80055 | <1% | 26 | $674.40 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 68 | $625.20 |
| V2632 | Posterior chamber intraocular lens | <1% | 69 | $572.81 |
| 97597 | <1% | 27 | $563.45 | |
| 86780 | <1% | 40 | $558.03 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 334 | $517.36 |
| 88142 | <1% | 27 | $479.56 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $405.79 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 23 | $395.89 |
| 82553 | <1% | 72 | $374.58 | |
| 86787 | <1% | 25 | $369.15 | |
| 82677 | <1% | 12 | $331.54 | |
| 84702 | <1% | 29 | $320.92 | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | <1% | 366 | $302.42 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 118 | $257.53 |
| 86336 | <1% | 12 | $230.45 | |
| 82105 | <1% | 12 | $229.90 | |
| 85730 | <1% | 62 | $219.29 | |
| 85610 | <1% | 76 | $185.72 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 65 | $156.47 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 38 | $130.24 |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 18 | $128.63 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 71 | $104.79 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 14 | $64.76 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 34 | $63.94 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 160 | $63.13 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 19 | $55.19 |
| 82077 | <1% | 13 | $49.98 | |
| 85014 | <1% | 19 | $44.25 | |
| 82565 | <1% | 14 | $19.08 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | $12.23 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 71 | $4.65 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANCOCK, MELINDA (CFO)
Parent organizationSENTARA HOSPITALS
| Provider | Location | Paid |
|---|---|---|
| Sentara Hospitals | Norfolk, VA | $88.20M |
| Sentara Hospitals | Norfolk, VA | $79.69M |
| Sentara Hospitals | Hampton, VA | $78.52M |
| Potomac Hospital Corporation of Prince William | Woodbridge, VA | $59.17M |
| Sentara Hospitals | Suffolk, VA | $57.85M |
| Sentara RMH Medical Center | Harrisonburg, VA | $52.95M |
| Sentara Hospitals | Virginia Beach, VA | $52.40M |
| Sentara Princess Anne Hospital | Virginia Beach, VA | $37.50M |
| Martha Jefferson Hospital | Charlottesville, VA | $26.95M |
| Halifax Regional Hospital, INC. | South Boston, VA | $23.28M |
| Sentara Hospitals | Williamsburg, VA | $21.89M |
| Sentara Reference Lab Solutions, LLC | Norfolk, VA | $4.74M |
| Halifax Regional Hospital, INC | South Boston, VA | $1.61M |
| Halifax Regional Hospital, INC | Nathalie, VA | $348K |
| Halifax Regional Hospital, INC | South Boston, VA | $336K |
| Halifax Regional Hospital, INC | Chase City, VA | $298K |
| Halifax Regional Hospital, INC | Clarksville, VA | $265K |
| Sentara Hospitals | Norfolk, VA | $171K |
| Halifax Regional Hospital, INC | South Boston, VA | $170K |
| Sentara Hospitals | Norfolk, VA | $128K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.